TTNP TITAN PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2023 - Private Placement and Purchase Agreement Titan Pharmaceuticals entered into a Securities Purchase Agreement with The Sire Group for a private placement of 950,000 shares of Series AA Convertible Preferred Stock, with a purchase price of $9.5 million.Get access to all SEC 8-K filings of the TITAN PHARMACEUTICALS INC